Brief: Matinas BioPharma Reports Second Quarter 2021 Financial Results And Operational Highlights
10/08/2021 11:32
Aug 10 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* Q2 LOSS PER SHARE $0.02
* Q2 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES
DATA
* BASED ON CURRENT PROJECTIONS, COMPANY BELIEVES THAT CASH
ON HAND
IS SUFFICIENT TO FUND OPERATIONS INTO 2024
Source text for Eikon: ID:nGNX9X9F6y
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing